MD Financial Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
EP
MD Financial Management's ARKG Position: Q4 2021 in Review
MD Financial Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 50 shares — an estimated $4K sold.
MD Financial Management first reported a position in ARKG in Q3 2021 and held it in 1 quarter. The position peaked at $4K in Q3 2021. 462 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.
- MD Financial Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
- MD Financial Management sold 50 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $4K.
- MD Financial Management first reported a position in ARK Genomic Revolution ETF in Q3 2021 and held it in 1 quarter.
- MD Financial Management's ARK Genomic Revolution ETF position peaked at $4K in Q3 2021.
- 462 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.
Based on MD Financial Management's 13F filing for Q4 2021, filed 14 Feb 2022.